Oct 17 (Reuters) - VALBIOTIS SAS ALVAL.PA :
* VALBIOTIS CONFIRMS ITS INTEREST IN THE STUDY OF THE
INTESTINAL
MICROBIOTA, A PROMISING FIELD IN THE PREVENTION OF METABOLIC
DISEASES
* VALBIOTIS COMPILES A BASE OF HUMAN DATA IN FIELD OF
METABOLIC
DISEASES, WITH HIGH VALUE POTENTIAL
* VALBIOTIS FOCUSES ON FRENCH POPULATION'S UNDERSTANDING OF
INTESTINAL MICROBIOTA THROUGH AN UNPRECEDENTED OPINÉA SURVEY
* VALBIOTIS DEVELOPS LEADING EXPERTISE IN THIS FIELD OF
RESEARCH
Source text for Eikon: ID:nBwbWYTTTa
Further company coverage: ALVAL.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))